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Abstract
Background Previous reviews indicate that depressed patients with a comorbid personality disorder (PD) tend to benefit 
less from psychotherapies for depression and thus personality pathology needs to be the primary focus of treatment. This 
review specifically focused on studies of Cognitive Behavioural Therapy (CBT) for depression examining the influence of 
comorbid PD on post-treatment depression outcomes.
Methods This was a systematic review and meta-analysis of studies identified through PubMed, PsychINFO, Web of Sci-
ence, and Scopus. A review protocol was pre-registered in the PROSPERO database (CRD42019128590).
Results Eleven eligible studies (N = 769) were included in a narrative synthesis, and ten (N = 690) provided sufficient data 
for inclusion in random effects meta-analysis. All studies were rated as having “low” or “moderate” risk of bias and there 
was no significant evidence of publication bias. A small pooled effect size indicated that patients with PD had marginally 
higher depression severity after CBT compared to patients without PD (g = 0.26, [95% CI: 0.10, 0.43], p = .002), but the 
effect was not significant in controlled trials (p = .075), studies with low risk of bias (p = .107) and studies that adjusted for 
intake severity (p = .827). Furthermore, PD cases showed symptomatic improvements across studies, particularly those with 
longer treatment durations (16–20 sessions).
Conclusions The apparent effect of PD on depression outcomes is likely explained by higher intake severity rather than 
treatment resistance. Excluding these patients from evidence-based care for depression is unjustified, and adequately lengthy 
CBT should be routinely offered.
Keywords Cognitive behavioural therapy · Depression · Personality disorder · Systematic review · Meta-analysis
Introduction
Personality disorders (PD) refer to an enduring pattern of 
inner experiences and interpersonal difficulties that sig-
nificantly deviate from the individual’s culture, which are 
inflexible and pervasive over a range of social scenarios. 
This pattern can often be traced back to adolescence or early 
adulthood and is not better explained as a manifestation of 
another mental health problem (American Psychiatric Asso-
ciation 2013). According to a recent systematic review (Win-
sper et al. 2019), the pooled global prevalence of PD has 
been estimated to be around 7.8%, with higher prevalence 
rates found in high-income countries (~9.6%) compared with 
low and middle-income countries (~4.3%). Cluster C dis-
orders, characterized by fearfulness and anxiety (avoidant, 
dependent, and obsessive–compulsive) are the most com-
mon in the general population with an estimated prevalence 
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of 5.0%. This is followed by Cluster A disorders with a 
prevalence of 3.8%, characterized by eccentric beliefs and 
interpersonal styles (paranoid, schizoid, and schizotypal). 
Cluster B disorders have the lowest estimated prevalence 
around 2.8%, and are characterized by intense emotional 
lability (antisocial, borderline, histrionic, and narcissistic).
PD are associated with considerable psychological dis-
tress, social problems, functional impairment, and premature 
mortality (Moran et al. 2016). Clinical guidelines for the 
management of PD recommend psychotherapy as a first line 
treatment (Simonsen et al. 2019). In spite of this, individu-
als with a PD are less likely to seek treatment compared to 
those with other mental health conditions (Andrews et al. 
2001), and particularly those with Cluster A disorders are 
more likely to reject treatment (Tyrer et al. 2003). Previ-
ous studies indicate that PD are highly comorbid with each 
other (Ekselius et al. 1994; McGlashan et al. 2000) and with 
other mental health problems (McGlashan et al. 2000). It is 
likely that frequent comorbidity among personality disorders 
is an artifact of an imperfect polythetic diagnostic system 
that assumes the existence of different and discrete types 
of PDs. This system has been substantially modified more 
recently, among other reasons because it produces high rates 
of comorbidity, dropping the different types of categorical 
PDs in favour of one single diagnosis of PD estimated within 
a severity continuum (Herpertz et al. 2017). In regards to 
comorbidity with other mental health problems, PDs are par-
ticularly comorbid with major depressive disorder (Corruble 
et al. 1996). For example, between 40 and 80% of depressed 
patients have been estimated to have comorbid PD, depend-
ing on the treatment setting, with cluster C disorders being 
most common (Friborg et al. 2014; Hirschfeld 1999; Wong-
pakaran et al. 2015).
Although the comorbidity of depression and PD is widely 
documented, the impact of personality pathology on depres-
sion treatment outcomes has been a matter of controversy for 
many years. Earlier systematic reviews on this topic reported 
mixed and inconclusive evidence (Kool et al. 2005; Mulder 
2002). Conversely, more recent reviews indicate that poorer 
treatment outcomes were found for depressed patients diag-
nosed with comorbid personality disorders (Newton-Howes 
et al. 2006, 2014). The latest of these reviews (Newton-
Howes et al. 2014) reported this overall finding consistently 
across subgroup analyses pooling data from electroconvul-
sive therapy samples, pharmacotherapy samples, psycho-
therapy samples and combined treatments. However, the 
specificity of this effect is less clear, since the meta-analysis 
for psychotherapy studies combined data from different 
forms of treatment (e.g., cognitive behavioural therapy, 
counselling, psychodynamic therapy, and other unspecified 
therapies). This is problematic because it has been suggested 
that, for example, specific types of psychotherapy may dif-
ferentially benefit patients with depression and avoidant 
versus obsessive personality traits (Barber and Muenz 1996), 
although this evidence is still inconclusive (Kikkert et al. 
2016). Moreover, relatively few studies of cognitive behav-
ioural therapy (CBT) were included in this review, despite 
the fact that CBT is one of the most widely studied and rec-
ommended treatments for depression (Chambless and Ollen-
dick 2001; National Institute for Health and Care Excellence 
2011). Other systematic reviews examining psychotherapy 
outcomes in the context of PD have tended to have a nar-
row scope, for example focusing on borderline personality 
disorder (e.g., Cristea et al. 2017; Davidson and Tran 2014) 
which has a comparatively low prevalence in typical clinical 
samples with depression (Wongpakaran et al. 2015).
Newer studies have emerged on the relation between PD 
and depression treatment outcomes (e.g., Harte and Hawk-
ins 2016; van Bronswijk et al. 2018), warranting a more 
focussed review of the evidence pertinent to contemporary 
CBT practice, and specifically of the effectiveness of CBT 
for depression in patients with comorbid PDs. This has 
potentially profound clinical implications. A co-morbid PD 
is found in roughly half of the patients who present with 
depression across clinical services and is predictive of sub-
optimal clinical outcomes for depression. As a result, clini-
cal algorithms developed for the care of patients present-
ing this comorbidity have typically posed that personality 
pathology needs to be addressed first, using evidence-based 
PD treatments, before depressive symptomatology can be 
improved (Gunderson 2014; Van and Kool 2018). This 
becomes problematic from the perspective of treatment 
availability and delivery, since evidence-based treatments for 
PDs are underdeveloped for disorders other than borderline 
personality disorder and in general very costly in time and 
money (Spong et al. 2020) and largely unavailable in health 
care systems across the globe (Paris 2020). Compared to 
evidence-based care for PDs, psychotherapy for depression 
is more often available across health care systems, particu-
larly in middle and high income countries, less costly and 
time consuming (Araya et al. 2018). CBT is one of the most 
widely studied and recommended treatments for depres-
sion (Chambless and Ollendick 2001; National Institute for 
Health and Care Excellence 2011) and, to the extent that it 
may be effective for the treatment of depression comorbid 
with PD, this would result in a large expansion of the avail-
ability of care for this group of patients when the primary 
treatment target is depressive symptomatology. Furthermore, 
this would lead to a potential modification of commonly 
used clinical algorithms and clinical wisdom regarding 
treatment sequences for patients with PDs (i.e., personality 
pathology needs to be treated before, in order to improve 
depressive symptomatology).
On this basis, the present study aimed to fill this gap in 
the literature through a systematic review and quantitative 
synthesis of CBT-specific studies investigating associations 
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between personality disorders and depression treatment 
outcomes.
Methods
The review protocol was registered in the international 
prospective register of systematic reviews (PROSPERO) 
database prior to the search being conducted (registration 
number: CRD42019128590). Informed consent from study 
participants was not required, as this study was a secondary 
analysis of results from primary studies that are available in 
scientific journals.
Search Strategy
The inclusion and exclusion criteria described in Table 1 
guided the development of a systematic search strategy 
which combined key terms (related to personality disorder, 
CBT, depression) using Boolean operators. The search was 
limited to peer-reviewed articles published in the English 
language, and was applied on 29th March 2019 across four 
databases: PsychINFO, SCOPUS, Web of Science, and 
PubMed. No restrictions were imposed on study publica-
tion dates. Furthermore, in order to derive findings that are 
treatment-specific, we only included studies that applied 
bona fide CBT treatment protocols, excluding related vari-
ations or adaptations (mindfulness-based interventions; 
ACT; DBT; CBASP; guided self-help adaptations of CBT) 
or components of CBT (i.e., behavioural activation). The 
full search strategy can be found in the online supplement 
(Online Appendix A).
Titles and abstracts were screened by the first author 
and relevant information was collated using the Cochrane 
Collaboration data extraction form (Higgins et al. 2019). 
Reverse-citations and reference list searches were conducted 
by hand on eligible studies to identify any further relevant 
studies.
Primary Outcome
The primary outcome of interest was depression treatment 
outcome, as determined by diagnostic interview or using 
validated self-rated or clinician-rated depression symptom 
measures. This review specifically focused on studies where 
depression treatment outcomes were compared between par-
ticipants with and without a personality disorder diagnosis.
Risk of Bias Assessment
Risk of bias was assessed using the CASP tool for cohort 
studies (Critical Appraisal Skills Programme 2018) and 
the revised Cochrane risk of bias tool for randomised trials 
(Sterne et al. 2019). Eligible papers were assessed indepen-
dently by two reviewers who later compared their ratings and 
arrived at a consensus without the need for moderation by a 
third reviewer. The reviewers had no disagreements in their 
final risk of bias ratings, so an interrater reliability calcula-
tion was deemed redundant and is therefore not reported.
Data Synthesis
A narrative (qualitative) review of all reviewed studies 
was conducted. A random effects meta-analysis was addi-
tionally completed for all studies that provided sufficient 
statistical information, using the statistical R package 
Meta-Analysis via Shiny (MAVIS; Hamilton et al. 2016). 
Statistical information examining between-group (No PD 
vs. PD) differences was standardised using Hedges’ g to 
enable meta-analysis, with adjustment for unequal sample 
sizes across groups, and to correct for small-sample bias. 
A single within-study pooled effect size was calculated for 
studies that reported more than one measure of depression 
symptoms. Where available, effect sizes adjusted for intake 
depression severity were selected for meta-analysis. Q and 
 I2 statistics enabled the examination of heterogeneity (Hig-
gins et al. 2003). A weight function model and fail-safe N 
calculation using Rosenthal’s method were also employed 
to investigate publication bias (Orwin 1983). The relatively 
small number of studies included in meta-analysis (<20) 
precluded the use of more detailed moderator analyses 
(Rubio-Aparicio et al. 2017), so we limited our investigation 
of heterogeneity using subgroup analyses according to study 
design features (experimental vs. observational; depression 
outcome measures; PD diagnosis methods; risk of bias rat-
ings; adjustment for intake depression severity). Finally, an 
exploratory analysis examined non-parametric (Spearman’s) 
correlations between effect sizes and the maximum duration 
of the CBT protocol used across studies (since mean treat-
ment duration was not consistently reported).
Results
Sample Characteristics and Measures
A PRISMA diagram summarising the search and selec-
tion process is displayed in Fig. 1. Eleven studies met the 
inclusion criteria and are described in Tables 2 and 3. The 
majority were randomised controlled trials (k = 7) and the 
remainder were observational cohort studies (k = 4). As 
shown in Table 3, the specific number of CBT patients 
with depression across all included studies was 769 (sam-
ple size range = 24–122). More than half (64.6%) of par-
ticipants across studies were females, mostly of a White 






























Table 1  Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Review question: Does the presence of a personality disorder influence depression treatment outcomes after Cognitive Behavioural Therapy?
 Population Participants, who are 18 and over, who had clinically signifi-
cant symptoms of depression
Studies where all participants were under the age of 18
Studies that did not screen participants for depression
 Intervention Studies where the participants received cognitive behavioural 
therapy (CBT); including studies with multiple treatments 
(e.g. controlled trials) where at least some participants 
accessed CBT
Studies where participants did not receive CBT
Studies of related variants of CBT (i.e., DBT, ACT, Mind-
fulness-based interventions, CBASP, guided self-help) or 
components (i.e., Behavioural Activation)
 Comparator Studies that examined the presence and/or severity of per-
sonality disorder diagnoses or traits, using any diagnostic 
interviews or validated screening measures
There will be no limitation as to what cluster of personality 
disorders are assessed
Studies that did not examine personality disorder diagnoses, 
traits or severity
Studies examining general / normative personality traits (i.e., 
big five personality traits)
 Outcomes Studies that measured post-treatment depression outcomes 
using diagnostic interviews or validated measures
Studies where post-treatment depression outcomes were not 
assessed
 Study design Randomised controlled trials and observational cohort studies
Studies published in peer reviewed scientific journals and 
written in the English language
Grey literature, such as academic theses, which are not pub-
lished in peer reviewed scientific journals
Editorials, newspaper or magazine articles and other forms of 
media
Literature sources not in published in English
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samples ranged from 32 to 42.5. All studies were con-
ducted in western countries. Employment status ranged 
considerably across studies (30–91%).
Most studies used self-reported depression measures 
as the primary outcome as shown in Table 2. The Beck 
Depression Inventory (BDI, BDI-II) and Hamilton Rating 
Scale for Depression (HRSD) were the two most com-
monly used measures. Other measures included the Mont-
gomery–Åsberg Depression Rating Scale (MADRS) and 
the Hopkins Symptom Checklist 90-item major depressive 
disorder subscale (HSCL-90 MDD).
Personality disorder diagnoses across most studies 
were obtained using the Structured Clinical Interview for 
the DSM (k = 7). A variety of editions of the DSM were 
used: DSM-III (n = 1), DSM-III-R (n = 5), DSM-IV (k = 2). 
Craigie et al. (2007), used the Millon Clinical Multiaxial 
Inventory-III to classify an individual’s personality disor-
der complexity. van den Hout et al. (2006) conducted two 
Records screened: Stage 1 tles 
and abstracts (n=4,872) 
Records excluded (n=4,799) 
Records assessed for eligibility: 
Stage 2 full-text review (n=74) 
Records excluded, with reasons 
explained in Appendix B (n=69) 
Studies idenfied through reverse-
citaons and reference lists of 
stage 2 records (n=6)
Number of studies included in 
qualitave synthesis (n=11) 
Number of studies included in 
quantave meta-analysis (n=10) 
Duplicates removed (n=32) 
































































Table 2  Characteristics of studies included in the review
RCT randomised control trial, N/A not available, MDU mood disorders unit, AUS Australia, CBT cognitive behavioural therapy, AT assertation training, BDI Beck depression inventory, OCS 
observational cohort studies, NLD Netherlands, USA United States of America, ADM anti-depression medication, HRSD Hamilton rating scale for depression, GBR Great Britain, PI psychody-
namic-interpersonal therapy, NZL New Zealand, IPT interpersonal psychotherapy, MADRS Montgomery–Åsberg Depression Rating Scale, HSCL-90 Hopkins symptom checklist, MDD major 
depressive disorder
a Data were analysed on the 16th week and the 12-month continuation phase
b Demographics were given for the whole sample, not the MDD patients of interest in this study
*Studies rated as “low risk of bias”; the rest were rated as “moderate risk of bias”
First author and year Study design Demographic informa-
tion: sex (M/F), age (M), 
ethnicity, employment 
status
Treatment setting Number 
analysed 
NPD/PD
Intervention condition Outcome measures Number of sessions
Ball et al. (2000) RCT 15/46, 42.5, N/A, 36% 
employed
MDU at Prince Henry 
Hospital, AUS
54/7 CBT or CBT/AT BDI 10
Craigie et al. (2007)* OCS 33/82, 38.6, N/A, 38.7% 
employed
Centre for clinical inter-
ventions, AUS
31/84 CBT BDI-II 10
Fournier et al. (2008) RCT 98/142, 40, 82% (white), 
82% employed
Research Clinic, USA 125/115 ADM or Placebo or CBT HRSD 16 with possible 
 continuationa
Hardy et al. (1995) RCT 54/60, 40.25, 65% 
(white), N/A
Clinical setting, GBR 87/27 PI or CBT BDI 8 or 16
Harte and Hawkins 
2016)




28/32 CBT BDI-II 12–16
Joyce et al. (2007)* RCT 41/136, 35.2, N/A, N/A Clinical setting, NZL 92/75 IPT or CBT MADRS 4–6
Kuyken et al. (2001)* OCS 69/93, 33.61, N/A, N/A Center for Cognitive 
Therapy, University of 
Pennsylvania, USA
26/96 CBT BDI-II N/A
Shea et al. (1990)* RCT 71/168, 35, 89% (white), 
N/A
Clinical setting, USA 61/178 CBT or IPT or Imi-
pramine and clini-
cal management or 
Placebo and clinical 
management
HRSD and HSCL-90 
depression scale
16–20
Tyrer et al. (1990) RCT 65/145b, 34.5, N/A, N/A Mapperley hospital, 
MRC biostatistics unit, 
GBR
30/31 Diazepam or dothiepin 
or placebo or CBT or 
self-help package
MADRS 10
van Bronswijk et al. 
(2018)
RCT 48/98, 41.3, N/A, 61.6% 
employed
Mood disorders unit of 
Maastricht Community 
Mental Health Centre, 
NLD
97/49 CBT or IPT BDI-II 16–20
van den Hout et al. 
(2006)
OCS 157/264b, 32.5, N/A, 
30% employed
Vincent van Gogh mental 
hospital, Venray, NLD
15/25 CBT HSCL-90 MDD subscale N/A
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Table 3  Main findings reported by studies included in the review
First author and year Personality disorder complex-
ity (N)
Personality disorder type (N) CBT sample sizes Summary of key findings 
specific to CBT samples






PD cases had higher mean 
depression severity at intake
NPD cases had greater 
improvements in depression 
symptoms posttreatment and 
at long-term follow-up (BDI 
post-treatment: NPD = 9.0 
vs. PD = 19.55; pooled 
SD = 13.25). There were 
no significant differences 
between PD Clusters over the 
assessment periods (F = 1.4, 
NS)
Results were not adjusted for 
intake depression severity









PD cases had higher mean 
depression severity at intake
Chi-square analysis showed 
that the NPD group had a 
significantly higher fre-
quency of CSI compared to 
the simple PD group, χ2 (1, 
N = 79) = 8.29, p < .01, and 
the complex PD group, x2 (1, 
N = 63) = 4.37, p < 05
BDI posttreatment: 
NPD = 12.52 (SD = 9.79); 
PD = 19.55 (SD = 25.6)
Results were not adjusted for 
intake depression severity






Differences in intake depres-
sion severity in NPD vs. PD 
cases were not reported
Depression treatment response 
rates were NPD = 70% vs. 
PD = 44% within the cogni-
tive therapy group
Results within the CT group 
were not adjusted for intake 
depression severity









PD cases had higher mean 
depression severity at intake
No significant differences 
in depression treatment 
outcome were found compar-
ing PD and NPD groups; 
F(1,45) = 1.10, p = 0.30
Results were adjusted for 
intake depression severity
568 Cognitive Therapy and Research (2021) 45:561–576
1 3
Table 3  (continued)
First author and year Personality disorder complex-
ity (N)
Personality disorder type (N) CBT sample sizes Summary of key findings 
specific to CBT samples






Intake depression severity 
scores were highly similar 
between NPD and PD cases
Among patients treated for 
depression, similar propor-
tions of patients in the NPD 
(40.6%) and PD (39.3%) 
groups recovered after treat-
ment; adjusted OR = 1.07 
(95% CI 0.34, 3.39), p = NS
Results were adjusted for 
intake depression severity









Differences in intake depres-
sion severity in NPD vs. PD 
cases were not reported
PD did not significantly predict 
post-treatment outcome for 
patients treated with CBT 
 (R2 = 0.018, p = NS). Post-
treatment % improvement in 
MADRS score: NPD = 66.1 
(SD = 33.8); PD = 57.5 
(SD = 28.7)
Results were not adjusted for 
intake depression severity






PD cases had higher mean 
depression severity at intake
The comparison of outcome 
by personality disorder was 
not significant for either 
self-rated depression sever-
ity or clinical-rated global 
functioning
BDI posttreatment: NPD = 7.23 
(SD = 10.55); PD = 9.54 
(SD = 12.57)
Results were not adjusted for 
intake depression severity
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Table 3  (continued)
First author and year Personality disorder complex-
ity (N)
Personality disorder type (N) CBT sample sizes Summary of key findings 
specific to CBT samples









Differences in intake depres-
sion severity in NPD vs. PD 
cases were not reported
Within the CBT treatment con-
dition NPD cases had similar 
albeit marginally higher 
depression severity compared 
to PD cases; this pattern 
was consistent in clinician-
reported and patient-reported 
measures
HRSD posttreatment: 
NPD = 11.94 (SD = 7.45); 
PD = 10.34 (SD = 7.45)
SCL-90 depression scale 
posttreatment: NPD = 1.30 
(SD = 0.97); PD = 1.23 
(SD = 1.01)
Pooled effect size across both 
measures, using Hedge’s g 
estimation: g = − 0.14
Results were adjusted for 
intake depression severity









PD cases had higher mean 
depression severity at intake
In the full sample including 
pharmacological, self-help 
and CBT treatments, PD 
cases had significantly higher 
posttreatment impairment 
across all measures, even 
after adjusting for intake 
severity. NPD and PD cases 
in the CBT treatment arm had 
similar levels of improvement 
over time
Results were adjusted for 
intake depression severity









PD cases had higher mean 
depression severity at intake
Within the CBT treatment arm, 
post-treatment BDI scores 
were highly similar between 
NPD and PD cases, albeit 
marginally higher in the NPD 
group
BDI posttreatment: NPD = 13.6 
(SD = 9.4); PD = 13.3 
(SD = 11.3)
Results were not adjusted for 
intake depression severity (in 
the specific contrast of NPD 
vs. PD within the CBT arm)
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clinical interviews with each of their patients but did not 
specify their diagnostic criteria. Shea et al. (1990) did not 
conduct clinical interviews but used a “Personality Assess-
ment Form” which screened for PD features based on the 
DSM-III. Tyrer et al. (1990) used a “Personality Assessment 
Schedule” as their clinical interview guide.
Prevalence of Personality Disorders
As shown in Table 3, most studies (k = 10) assessed dif-
ferent personality clusters in their sample, with the most 
common being cluster C (52.5%) across all studies. Six stud-
ies assessed personality disorder complexity, where “sim-
ple PD” refers to a single PD diagnosis and “complex PD” 
refers to cases meeting criteria for two or more PD. Pooled 
data from available studies indicates that approximately 
49.3% of study participants did not have a PD, 28.0% met 
criteria for a single PD, and 22.7% met criteria for two or 
more PD (complex PD). Furthermore, CBT-specific samples 
across included studies indicated that around half (53.4%) of 
patients met criteria for a PD.
Risk of Bias Assessment
Most studies generally had low risk of bias. Five stud-
ies were rated as “low risk” and six studies were rated as 
“moderate risk”. No studies were regarded as “high risk”. 
The main sources of bias were lack of inclusion of all PD 
clusters, not analysing missing outcomes data, unclear ran-
domisation procedures and blinding in clinical trials, and 
not addressing the implications of the outcomes found in the 
study. Tables showing risk of bias ratings for all reviewed 
studies can be found in the online supplement.
Narrative Synthesis of Findings Across Studies
Key findings in CBT-specific samples are presented in 
Table 3. Most studies (k = 7) reported higher intake depres-
sion severity scores for cases with PD; three studies did not 
report intake severity comparisons (Fournier et al. 2008; 
Joyce et al. 2007; Shea et al. 1990) and only one study 
reported similar intake severity scores (Harte and Hawkins 
II). PD cases were also more likely to have a higher number 
of comorbid Axis I disorders and overall clinical and social 
impairment at intake. However, few studies (k = 4) analysed 
treatment outcome comparisons adjusted for intake depres-
sion severity (Hardy et al. 1995; Harte & Hawkins II; Shea 
et al. 1990; Tyrer et al. 1990).
Across most studies (k = 9) PD cases tended to have 
higher mean depression symptoms after treatment, although 
the magnitude and significance of this trend varied consider-
ably across studies (see Table 3). Only two studies reported 
Table 3  (continued)
First author and year Personality disorder complex-
ity (N)
Personality disorder type (N) CBT sample sizes Summary of key findings 
specific to CBT samples






PD cases had higher mean 
depression severity at intake
Within the group of depressed 
CBT patients, the pro-
portions with clinically 
significant improvement were 
NPD = 80% vs. PD = 52% (χ2 
[df = 1] = 3.1, p = 0.038)
Results were not adjusted for 
intake depression severity
Totals (within studies that 
reported each feature)
Total = 957
Simple PD: 268 (28.0%)
Complex PD: 217 (22.7%)
No PD: 472 (49.3%)
Total = 1066
Cluster A: 153 (14.4%)
Cluster B: 186 (17.4%)
Cluster C: 560 (52.5%)
PD NOS: 167 (15.7%)
Total = 769
NPD = 358 (46.6%)
PD = 411 (53.4%)
The prevalence of personality disorder clusters is taken from the largest available sample in each study, in order to minimise selection bias and 
to render more accurate estimates of overall prevalence in typical clinical samples. The column of statistical results is drawn specifically from 
subsamples of CBT cases in studies where the full sample may have included other treatments (i.e., pharmacotherapy or other psychological 
interventions)
N/A not available, PD personality disorder, NOS not otherwise specified, NPD no personality disorder
Cluster A refers to: paranoid, schizoid, and schizotypal personality disorders
Cluster B refers to: antisocial, borderline, histrionic, and narcissistic personality disorders
Cluster C refers to: avoidant, dependent, and obsessive–compulsive personality disorders
PD NOS (personality disorders not otherwise specified) refers to problems with inter and intrapersonal functioning that are not accounted for by 
the specific diagnoses defined by the Diagnostic Statistical Manual (DSM) or International Classification of Diseases (ICD)
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the opposite trend, where cases with no PD had margin-
ally higher depression severity after treatment, but this was 
not statistically significant (Shea et al. 1990; van Bronswijk 
et al. 2018). Although some studies indicated that PD cases 
tended to improve less than those without PD, PD cases did 
nevertheless benefit from CBT and often made considerable 
improvements. For example, Hardy et al. (1995) reported a 
large within-group effect size (d = 2.41) on the BDI measure 
for CBT cases with a PD, albeit in a small sample (N = 14). 
A study with a larger sample (N = 54) also showed a large 
(d = 1.18)1 within-group effect size on the BDI measure for 
PD cases treated with CBT (Ball et al. 2000). Furthermore, 
improvements in depression severity were maintained for 
cases with PD in studies that carried out longer-term follow-
up assessments (e.g., Ball et al. 2000; Hardy et al. 1995; van 
Bronswijk et al. 2018).
Studies examining the relationship between PD complex-
ity and treatment outcomes had mixed and contradictory 
findings. Similarly, studies that examined the relationship 
between PD and dropout/attrition had inconsistent find-
ings. Joyce et al. (2007) and Kuyken et al. (2001) examined 
relationships between specific personality traits and post-
treatment BDI-II scores. Joyce et al. (2007) did not find 
significant associations between specific PD diagnoses and 
CBT treatment outcomes. The study by Kuyken et al. (2001) 
found that, although PD diagnosis was unrelated to CBT 
treatment outcomes, maladaptive avoidant and paranoid 
beliefs predicted poorer treatment outcomes after controlling 
for intake severity (avoidance predicted poorer depression; 
paranoia predicted poorer general functioning).
Meta‑analysis
Ten studies (N = 690) provided sufficient data for inclu-
sion in the primary meta-analysis examining associations 
between PD and post-treatment depression severity. The 
weighted mean effect size was g = 0.26, (95% CI 0.10, 0.43), 
p = 0.002, indicating that the presence of a PD was signifi-
cantly associated with higher post-treatment depression 
severity (see Fig. 2). Cochran’s Q-test (Q[9] = 7.71, p = 0.56) 
and the  I2 statistic (0.0%) indicated no significant evidence 
of heterogeneity. The regression for funnel plot asymme-
try and Kendall’s tau indicated no significant evidence of 
publication bias, t(8) = 0.47, p = 0.652; Kendall’s τ = 0.07, 
p = 0.862; Failsafe N = 26. The corresponding funnel plot 
for the main analysis is available in the online supplement 
(Online Appendix D).
Sub-group analyses were conducted to examine the 
potential influence of methodological features on the mag-
nitude of the observed effect size. The effect size in the sub-
group of studies using the BDI depression measure (k = 6; 
N = 451) was similar to the main analysis (g = 0.23, [95% 
CI 0.01, 0.44], p = 0.037) and with no significant heteroge-
neity (Q[5] = 3.65, p = 0.601,  I2 = 0.0%). The effect size in 
the subgroup of studies using DSM-based diagnostic inter-
views for PD (k = 7; N = 476) was similar to the main analy-
sis (g = 0.26, [95% CI 0.06, 0.46], p = 0.012) and with no 
significant heterogeneity (Q[6] = 5.00, p = 0.544,  I2 = 0.0%). 
The effect size in the subgroup of studies rated as having low 
risk of bias (k = 5; N = 448) was smaller compared to the 
main analysis (g = 0.17, [95% CI − 0.04, 0.38]), not statisti-
cally significant (p = 0.107), and with no significant hetero-
geneity (Q[4] = 2.69, p = 0.610,  I2 = 0.0%). The effect size in 
the subgroup of randomised controlled trials (k = 6; N = 389) 
was similar to the main analysis (g = 0.25, [95% CI − 0.03, 
0.52]), but not statistically significant (p = 0.075), and 
Fig. 2  Random effects meta-
analysis: effect of personality 
disorder (PD) on post-treatment 
depression severity
   Favours cases with PD                               Favours cases without PD
Effect size (g)
Primary meta-analysis [k=10; N=690]
Subgroup adjus ng for intake severity [k=3; N=140]
1 This effect size was calculated pooling available pre- and post-treat-
ment means and standard deviations for Cluster B and Cluster C cases 
with PD.
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with no significant heterogeneity (Q[5] = 6.29, p = 0.279, 
 I2 = 31.5%). The effect size in the subgroup of studies that 
adjusted for intake depression severity (k = 3; N = 140) was 
small and non-significant (g = 0.04, [95% CI − 0.33, 0.42], 
p = 0.827), compared to the results from studies that did not 
adjust for intake severity (k = 7; N = 550; g = 0.32, [95% 
CI 0.13, 0.51], p < 0.001). Tests for heterogeneity in both 
of these subgroup analyses were not significant (p > 0.05; 
 I2 = 0.0%).
A strong and statistically significant inverse correlation 
was found between CBT treatment-protocol duration and 
effect sizes (r = − 0.76, p = 0.016).
Discussion
Summary of the Evidence
This systematic review and meta-analysis found that patients 
meeting diagnostic criteria for a PD tended to improve less 
than patients without a PD after CBT for depression. There 
was no significant evidence of publication bias and the fail-
safe N calculation suggested that 26 studies with null find-
ings would be required to contradict the primary meta-anal-
ysis results. However, the effect size for this association was 
small (g = 0.26) and was not statistically significant in sam-
ples from RCTs, studies with low risk of bias, and studies 
that adjusted for intake depression severity. According to our 
narrative synthesis of the literature, there was some evidence 
of depression intake severity differences between cases with 
simple vs. complex PD, but little evidence that PD complex-
ity influenced treatment outcomes, although there was insuf-
ficient data across studies to verify this observation using a 
moderator analysis. Furthermore, the apparent detrimental 
effect of PD was lower in studies that offered longer CBT 
treatments, as evidenced by a strong (r = − 0.76) and signifi-
cant negative correlation between effect sizes and treatment 
duration. Finally, there was mixed and inconclusive evidence 
of associations between PD with treatment dropout.
Methodological and Conceptual Issues
There was considerable variability in methods used to assess 
PD and depression across all included studies. However, we 
found no significant evidence of effect size heterogeneity 
related to diagnostic interviews or depression rating tools. 
The main methodological sources of variability in outcomes 
were related to study design (RCTs vs. observational stud-
ies), risk of bias, and adjustment for intake severity.
Most studies reported higher intake severity and impair-
ment in PD cases. Prior evidence suggests that PDs are asso-
ciated with adverse early life events (e.g., Porter et al. 2020), 
with an earlier onset of comorbid Axis I disorders such as 
depression (Corruble et al. 1996) and thus greater severity 
and dysfunction by the time that patients access treatment. 
Despite this evident relationship between PD status and 
initial impairment, few studies (k = 4) analysed treatment 
outcome comparisons adjusted for intake depression sever-
ity, and associations between PD and treatment outcomes 
in this subgroup were minimal in magnitude (g = 0.04) and 
not statistically significant. This suggests that the apparently 
adverse effect of PD is mostly explained by intake severity 
rather than some form of treatment resistance or intractabil-
ity. This explanation is further supported by the observation 
that PD cases did in fact improve across all studies, and 
treatment gains were maintained at longer follow-ups. The 
effect of PD was not significant in RCTs, which is plausibly 
explained by the extent to which CBT was closely supervised 
and adherence closely monitored, particularly in studies with 
low risk of bias–which also showed non-significant effects of 
PD. Taken together, these findings suggest that patients with 
PD tend to be more severely depressed and impaired, but 
they can benefit considerably from CBT in contexts where 
therapy is closely supervised, delivered with adherence to 
treatment manuals, and with a sufficiently lengthy treatment 
duration (e.g., 16–20 sessions). This conclusion fits with 
prior meta-analytic studies that indicate that the efficacy of 
CBT is well-established in the context of personality disor-
ders (e.g., see Hofmann et al. 2012).
Basic conceptual issues regarding diagnosis of depression 
and personality disorders should also be considered. First, 
depression is increasingly viewed as a rather heterogene-
ous clinical entity (Fried and Nesse 2015). Thus, research 
looking at the concurrent presentation of depression and PD 
may not be nuanced enough to draw relevant and conclu-
sive findings. For example, Köhling et al. (2015) isolated a 
specific phenotype of depression in patients diagnosed with 
Borderline Personality Disorder (BPD), and in an impor-
tant longitudinal study over 24 years, Zanarini et al. (2019) 
discovered that depression was significantly more likely to 
be present in patients with BPD compared to patients with 
other PD, even though recurrence and remission rates over 
time were comparable in both groups. It is possible that 
CBT may be particularly suited for cases in which a true 
comorbidity is present, but limited in cases where depres-
sion is secondary to PD. These diagnostic nuances may par-
tially dilute overall effects when depression is viewed as a 
consistent syndrome. If they are, in fact, distinct disorders, 
psychotherapies including CBT should exhibit a good effect 
on depressive symptomatology regardless of comorbid per-
sonality dysfunction. If the opposite is true and both disor-
ders are related, then psychotherapy may exhibit restricted 
effectiveness. This may be the case for depression in the 
context of BPD, or in depressive phenotypes characterized 
by excessive self-criticism as proposed by Huprich (2019) 
and Dinger et al. (2015). Furthermore, the temporal stability 
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of PD diagnosis varies across PD subtypes (e.g., 63% for 
cluster B and 48% for cluster C).
Strengths and Limitations
To our knowledge, this review is the first to specifically 
assess the influence of PD on depression treatment outcomes 
after CBT. The study shows several hallmarks of good prac-
tice in systematic review; such as the pre-registration of the 
study protocol ahead of conducting searches, a comprehen-
sive and inclusive search strategy applied across multiple 
databases, forward and reverse citation searches, a double-
rated risk of bias assessment, and a quantitative synthesis 
using meta-analysis.
There are, however, also some limitations that warrant 
consideration. In spite of its inclusivity of studies without a 
publication date restriction, the review excluded any form 
of grey literature and studies that were not written in the 
English language. Whilst subgroup analyses were conducted 
to investigate methodological sources of heterogeneity, the 
relatively small set of studies precluded more robust mod-
erator analyses. Only five studies reported attrition rates 
and assessed whether there was any relationship between 
dropout and PD diagnosis. Even though none of these stud-
ies found a significant relationship between dropout and PD 
diagnosis, this does not rule out the potential influence of 
attrition bias in the remaining studies. Similarly, only six 
studies reported PD complexity, so the findings in relation 
to complexity are derived from a small subset. An additional 
limitation of the study concerns the issue of severity in per-
sonality disorders. Most studies included in this review used 
DSM-IV categorical diagnoses without the inclusion of a 
dimensional severity gradient, which would enable a bet-
ter examination of the relevance of PD severity. New stud-
ies that measure personality dysfunction on a dimensional 
scale and which control for pre-treatment depression severity 
could enable future moderator analyses. Finally, the variable 
follow-up durations across the few studies that examined 
longer-term effects precluded an examination of long-term 
treatment outcomes and relapse rates in relation to PD.
Implications for Research and Practice
Previous reviews by Newton-Howes et al. (2006, 2014) are 
indicative of a detrimental effect of PD in psychotherapy 
studies, with a small-to-moderate effect size (OR = 2.01; 
approximate d = 0.38). On this basis, clinical guidelines and 
conventional wisdom often suggest that when depression and 
PDs are concurrent, PD needs to be the main therapeutic tar-
get. However, as they state, their review is broad and it looks 
at all treatment types, both psychopharmacology and psy-
chotherapy, whereas the present study specifically focuses 
on CBT. In the current meta-analysis, the overall effect of 
PD on depression outcomes after CBT is smaller (g = 0.26) 
than previously assumed, and not statistically significant in 
contexts where CBT is delivered with high fidelity (i.e., in 
controlled trials) and with a longer treatment duration. Even 
though CBT delivery in most real-world clinical settings is 
less controlled than in clinical trials, this evidence suggests 
that depression can be improved in patients with concurrent 
depression and PDs, and that traditional sequencing algo-
rithms could in fact be modified, resulting in an expansion of 
access to evidence-based treatment for this group of patients.
An important theoretical question arising from this lit-
erature concerns how to optimize CBT for the treatment 
of depressed patients with a PD. One possibility is that 
allowing for a higher-than-average treatment duration may 
in itself be sufficient to allow for severe symptomology 
(typical of PD samples) to subside. Another possibility is 
that incorporating treatment strategies specifically target-
ing core beliefs (e.g., Beck et al. 2015) may be necessary 
to help patients with more chronic and entrenched mala-
daptive beliefs and interpersonal difficulties. For example, 
the study by Kuyken et al. (2001) found that PD diagnostic 
status was unrelated to depression treatment outcomes, but 
avoidant and paranoid maladaptive beliefs predicted poorer 
treatment response even after adjusting for intake severity. 
Future studies could empirically test these hypotheses, for 
example by randomising depressed patients with PD to low 
intensity (i.e., eight sessions) CBT without core-belief work 
versus high-intensity CBT (i.e., 16–20 sessions) with versus 
without core belief work. Further research is also needed to 
explore which specific traits and domains of personality dys-
function account for a restriction of therapeutic benefits of 
psychotherapy in general and CBT in particular, and which 
components of PD are innocuous in this regard, or even ben-
eficial, as in the case of anaclitic depressive styles (Luyten 
et al. 2017).
The diagnosis of PD has experienced significant shifts 
in the last few years, particularly since the publication of 
ICD-11 where different types of PD are dropped in favour 
of a single diagnosis of Personality Disorder and a gradi-
ent of severity (Herpertz et al. 2017). Yet, it remains con-
troversial in mental healthcare, and it has been argued that 
it can result in stigma and exclusion from evidence-based 
treatments (Kealy and Ogrodniczuk 2010; Snowden and 
Kane 2003; Stalker et al. 2005). When clinicians wish to 
help their patients with their depressive symptoms, in our 
view, the modest effect of PD on depression treatment out-
comes can hardly justify the widespread clinical algorithm 
of postponing evidence-based psychotherapy for depression 
in favour of treatments targeting PDs and thus, CBT should 
be routinely available to them, particularly in the setting of 
stepped-care models (Paris 2013; Spong et al. 2020). Still, 
the routine assessment of specific PD traits (and related 
maladaptive beliefs and behaviours) could support the 
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personalised delivery of CBT to make it more responsive 
to the needs of this patient group. The adoption of reliable 
screening of personality dysfunction in routine CBT practice 
could improve therapists’ ability to personalise treatment, by 
including the individual’s personality traits and relational 
history in case formulation and treatment planning.
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